# Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers

> **NCT04171752** · PHASE1 · COMPLETED · sponsor: **Genfit** · enrollment: 21 (actual)

## Conditions studied

- Geriatrics
- Healthy

## Interventions

- **DRUG:** elafibranor

## Key facts

- **NCT ID:** NCT04171752
- **Lead sponsor:** Genfit
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-22
- **Primary completion:** 2020-03-22
- **Final completion:** 2020-03-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171752, "Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04171752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*